Anne Krush Lecture
Moderators: Cathryn Koptiuch
Krush Introduction
Counseling of Children for Adult Onset Conditions, Leila Jamal
Q&A
Patient Perspective on Young Onset Cancer and Genetic Testing, Danielle Ripley-Burgess
Q&A

Presidential Plenary I
Moderators: Swati Patel & Peter Stanich

O-001 - The immune profile of Lynch syndrome-associated colorectal adenomas pinpoints the main determinants of immune activation, Lena Bohaumilitzky
O-002 - Who falls between the cracks? Geographic analysis and factors associated with genetic testing completion in colorectal cancer patients, Mary G. Smithson
O-003 - Racial Disparities in Tumor Microbiome in Young-Onset and Average-Onset Colorectal Cancer, David Liska
O-004 - Genetic Etiology of Constitutional {MLH1} Promoter Hypermethylation: Sixteen-Year Experience from a Single Diagnostic Laboratory, Megan F Hoenig
O-005 - Outcomes of the IMMray PanCan-d™ test in high-risk individuals undergoing pancreatic surveillance: Pragmatic data and lessons learned, Bryson W Katona
O-006 - Determinants of Signet Ring Cell Carcinoma in Hereditary Diffuse Gastric Cancer, Ophir Gilad

Break: Coffee & Snacks

CCARE Lynch Poster Walk

Moderators: Elena Levinson & Fay Kastrinos

P-065 One of these is not like the others: a descriptive study of the attenuated phenotype of PMS2, Brandie Heald
P-081 Colorectal cancer risk factors in Lynch syndrome: {MSH2}, advanced adenomas and adenomas multiplicity, Joaquin Castillo
P-083 Attitudes towards prevention options in Lynch Syndrome (LS): comparing frameshift peptide vaccination (FSPVAX), colonoscopy (COLO), and aspirin (ASA), Michael Hall
P-092 Cost-effectiveness of universal germline vs sequential screening for Lynch syndrome in patients with incident colorectal cancer in the United States, Xavier Llor
P-033 Frequency of Mismatch Repair Tumor Deficiency and Lynch Syndrome in Diverse Colorectal Cancer Patients at a Safety-Net Medical Center, Yvonne Cardona

Gastric Cancer
Moderators: Maegan Roberts & Carol Burke

Gastric Cancer Risk and Screening Recommendations in Hereditary Breast Cancer Syndromes, Bryson Katona
Q&A
Debate Format Introduction & Audience Poll
Early surgical management in CDH1, Sonia Kupfer
Extended endoscopic surveillance in CDH1, Massimiliano di Pietro
Cross Examination by Moderators and Rebuttals
Q&A